Clinical Trial Update: Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway. [Phase 2]

View source ↗

Summary

Phase 2 pilot trial assessing mesalazine for chemoprevention in colorectal cancer by evaluating its effect on beta-catenin signaling; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: SOFAR S.p.A. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED